Zhang J, Ji D, Shen W, Xiao Q, et al. Phase I Trial of a Novel Anti-HER2 Antibody-drug Conjugate, ARX788, for the Treatment of HER2-positive Metastatic Breast Cancer. Clin Cancer Res 2022 May 26. pii: 699249. doi: 10.1158/1078-0432.CCR-22-0456.
PMID: 35617525